Standard Biotools Stock Price on December 5, 2024
| LAB Stock | USD 1.94 0.08 3.96% |
Below is the normalized historical share price chart for Standard Biotools extending back to February 10, 2011. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Standard Biotools stands at 1.94, as last reported on the 12th of December 2024, with the highest price reaching 2.07 and the lowest price hitting 1.87 during the day.
If you're considering investing in Standard Stock, it is important to understand the factors that can impact its price. Standard Biotools owns Efficiency Ratio (i.e., Sharpe Ratio) of -6.0E-4, which indicates the firm had a -6.0E-4% return per unit of risk over the last 3 months. Standard Biotools exposes twenty-eight different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Standard Biotools' Risk Adjusted Performance of 0.0156, coefficient of variation of 9829.1, and Semi Deviation of 4.38 to confirm the risk estimate we provide.
At present, Standard Biotools' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 83.1 M, whereas Liabilities And Stockholders Equity is forecasted to decline to about 228.8 M. . At present, Standard Biotools' Price Book Value Ratio is projected to slightly decrease based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 2.08, whereas Price To Sales Ratio is forecasted to decline to 1.56. Standard Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 29th of July 2003 | 200 Day MA 2.1586 | 50 Day MA 1.8416 | Beta 1.569 |
Standard |
Sharpe Ratio = -6.0E-4
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | LAB |
Estimated Market Risk
| 4.33 actual daily | 38 62% of assets are more volatile |
Expected Return
| 0.0 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Standard Biotools is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Standard Biotools by adding Standard Biotools to a well-diversified portfolio.
Price Book 1.5367 | Enterprise Value Ebitda (19.22) | Price Sales 4.8233 | Shares Float 48.8 M | Wall Street Target Price 3.0833 |
Related Headline
Neuronetics Headline on 5th of December 2024
Head to Head Analysis Stryker and Neuronetics by thelincolnianonline.com
Neuronetics and Stryker are both medical companies, but which is the superior stock We will contrast the two companies based on the strength of their profitability, dividends, valuation, institutional ownership, analyst recommendations, earnings and risk. Risk Volatility Neuronetics has a beta of 2.25, suggesting
Standard Biotools Valuation on December 5, 2024
It is possible to determine the worth of Standard Biotools on a given historical date. On December 5, 2024 Standard was worth 1.83 at the beginning of the trading date compared to the closed value of 1.76. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Standard Biotools stock. Still, in general, we apply an absolute valuation method to find Standard Biotools' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Standard Biotools where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Standard Biotools' related companies.
| Open | High | Low | Close | Volume | |
| 1.82 | 1.88 | 1.76 | 1.85 | 1,179,141 | |
12/05/2024 | 1.83 | 1.85 | 1.76 | 1.76 | 979,061 |
| 1.77 | 1.84 | 1.73 | 1.82 | 872,837 |
| Backtest Standard Biotools | | | Standard Biotools History | | | Standard Biotools Valuation | Previous | Next |
Standard Biotools Trading Date Momentum on December 5, 2024
| On December 06 2024 Standard Biotools was traded for 1.82 at the closing time. Highest Standard Biotools's price during the trading hours was 1.84 and the lowest price during the day was 1.73 . The net volume was 872.8 K. The overall trading history on the 6th of December contributed to the next trading period price jump. The trading delta at closing time to the next next day price was 3.41% . The trading price change to current price is 17.61% . |
Standard Biotools Fundamentals Correlations and Trends
By evaluating Standard Biotools' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Standard Biotools' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Standard financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Standard Biotools Stock history
Standard Biotools investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Standard is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Standard Biotools will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Standard Biotools stock prices may prove useful in developing a viable investing in Standard Biotools
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 79.2 M | 83.1 M | |
| Net Loss | -171.1 M | -162.5 M |
Standard Biotools Quarterly Net Working Capital |
|
Standard Biotools Stock Technical Analysis
Standard Biotools technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Standard Biotools Period Price Range
Low | December 12, 2024
| High |
0.00 | 0.00 |
Standard Biotools cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Standard Biotools December 12, 2024 Market Strength
Market strength indicators help investors to evaluate how Standard Biotools stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Standard Biotools shares will generate the highest return on investment. By undertsting and applying Standard Biotools stock market strength indicators, traders can identify Standard Biotools entry and exit signals to maximize returns
Standard Biotools Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Standard Biotools' price direction in advance. Along with the technical and fundamental analysis of Standard Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Standard to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0156 | |||
| Jensen Alpha | (0.19) | |||
| Total Risk Alpha | (0.64) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | 0.0171 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Standard Stock analysis
When running Standard Biotools' price analysis, check to measure Standard Biotools' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Standard Biotools is operating at the current time. Most of Standard Biotools' value examination focuses on studying past and present price action to predict the probability of Standard Biotools' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Standard Biotools' price. Additionally, you may evaluate how the addition of Standard Biotools to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| CEOs Directory Screen CEOs from public companies around the world |